Shares of Cronos Group Inc. (TSE:CRON – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as C$4.72 and last traded at C$4.71, with a volume of 79273 shares trading hands. The stock had previously closed at C$4.58.
Analysts Set New Price Targets
Separately, TD upped their target price on Cronos Group from C$5.50 to C$6.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Cronos Group has an average rating of “Buy” and an average target price of C$4.92.
Check Out Our Latest Stock Analysis on CRON
Cronos Group Trading Up 3.1%
About Cronos Group
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.
See Also
- Five stocks we like better than Cronos Group
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
- If Boeing Ramps Up Production, These Suppliers May Win Big
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
